TerminatedNot Applicable

Efficacy of Bilateral Modified Catheter Antegrade Cerebral Perfusion in Acute Type A Aortic Dissection Surgery

Stopped: Terminated due to insufficient enrollment to achieve desired statistical power. A new IRB approval will be sought to extend the retrospective data collection period.

Taiwan273 participantsStarted 2021-01-01

Plain-language summary

This retrospective cohort study aims to evaluate the efficacy of a Bilateral Modified Catheter Antegrade Cerebral Perfusion (Modified bACP) technique in acute Type A aortic dissection surgery. Medical records from January 1, 2021, through October 31, 2024, at China Medical University Hospital will be reviewed. The primary outcomes include in-hospital mortality and stroke rate, while secondary outcomes include ICU/hospital stay, mechanical ventilation duration, and other postoperative complications (e.g., acute kidney injury, sepsis, myocardial infarction).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults (≥ 18 years old) who underwent acute Type A aortic dissection repair at China Medical University Hospital between January 1, 2021, and October 31, 2024. Exclusion Criteria: * Preexisting severe neurological impairment (e.g., stroke or other major neurological deficits before surgery). * Age \< 18 years. * Pregnant patients. * Insufficient or missing medical records preventing data analysis.

What they're measuring

Stroke

Timeframe: Through hospital discharge (on average about 14 days post-surgery)

Trial details

NCT IDNCT06943716

SponsorChina Medical University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-10-31

View on ClinicalTrials.gov More Acute Type A Aortic Dissection trials